Dr. Krakow is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-520-5700- Is this information wrong?
Education & Training
Universite de MontrealFellowship, Hematopoietic Cell Transplantation, 2010 - 2014- McMaster UniversityFellowship, Hematology, 2006 - 2008
Duke University HospitalResidency, Internal Medicine, 2003 - 2006
McGill University Faculty of MedicineClass of 2003
Certifications & Licensure
WA State Medical License 2009 - 2026
Clinical Trials
- Rivogenlecleucel Donor Lymphocyte Immunotherapy in Treating Patients With Recurrent Blood Cancers After Stem Cell Transplant Start of enrollment: 2020 Jan 02
- IFN-γ to Treat Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) That Has Relapsed After Allogeneic Hematopoietic Stem Cell Transplantation Start of enrollment: 2021 Mar 08
Publications & Presentations
PubMed
- Returning to Work Following Hematopoietic Cell Transplantation: The Survivor's Perspective.Xinyi Fan, Ailie Armstrong, Masumi Ueda Oshima, Karen L Syrjala, Rachel B Salit, Stephanie J Lee, Neel S Bhatt, Paul A Carpenter, Laura Connelly-Smith, Elizabeth Krako...> ;Transplantation and Cellular Therapy. 2024 Mar 30
- 4 citationsFatigue in Hematopoietic Cell Transplantation Survivors: Correlates, Care Team Communication, and Patient-Identified Mitigation Strategies.Christina K Ullrich, Kelsey K Baker, Paul A Carpenter, Mary E Flowers, Ted Gooley, Sarah Stevens, Elizabeth F Krakow, Masumi U Oshima, Rachel B Salit, Phuong Vo, Laura...> ;Transplantation and Cellular Therapy. 2023 Mar 1
- Trans-population graph-based coverage optimization of allogeneic cellular therapy.Sapir Israeli, Elizabeth F Krakow, Martin Maiers, Corinne Summers, Yoram Louzoun> ;Frontiers in Immunology. 2023 Jan 1
- Join now to see all
Abstracts/Posters
- BMT CTN 1803: Haploidentical Natural Killer Cells (CSTD002) to Prevent Post-Transplant Relapse in AML and MDS (NK-REALM)Elizabeth Krakow, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- BMT CTN 1803: Haploidentical Natural Killer Cells (CSTD002) to Prevent Post-Transplant Relapse in AML and MDS (NK-REALM)Elizabeth Krakow, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Ibrutinib in Relapsed or Refractory Transformed Indolent B-Cell Non-Hodgkin Lymphoma: Final Results from a Prospective Phase II StudyElizabeth Krakow, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
ElevateBio’s HighPassBio Presents on Novel T Cell Receptor Cell Therapy for Leukemia Relapse at 62nd Annual ASH MeetingDecember 6th, 2020
Hospital Affiliations
Fred Hutchinson Cancer CenterSeattle, Washington
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
